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SI Methods
Cells.Huh7 cells were plated at 3 105 or 2 106 cells per 6-well
or 10-cm dish and transfected with expression plasmids and a
reporter construct.
Histology and Immunohistochemistry. Mouse livers from different
genetic and treatment groups were fixed in neutral-buffered 4%
paraformaldehyde at 4°C and processed for paraffin embedding.
Five-micrometer sections were stained with hematoxylin and eosin.
Immunohistochemistry staining of cryosections or paraffin sections
was performed by using antibodies against TLR4 (HTA125; eBio-
science), phospho-JNK (Santa Cruz Biotechnology), phospho-IB
(Cell Signaling Technology), TNF- (RM9011; CALTAG), or
Nanog (Abcam) based on the standard protocol with mounting
media, including DAPI for nuclei counterstaining (Vector Labo-
ratories), according to the manufacturer’s recommendations.
Human Subjects. Necropsy liver tissues from patients with HCV
infection with or without a history of alcoholism were obtained as
cryopreserved samples according to the approved Institutional
Review Board protocol. The samples were carefully screened for
coinfection with other hepatitis virus or HIV as determined by
serological tests, drug addiction, and comorbidities other than
alcoholism as tested by clinical laboratory tests, and such samples
were excluded from the study. Necropsy liver specimens from 8
HCV infected patients were examined for immunohistochemistry
and immunoblat analysis. Four patients had a history of having
more than 4 drinks per day for more than 15 years. The other 4
patients reportedly consumed alcohol only occasionally in a very
moderate amount. They were all male with ages of 2759 years, but
no information on smoking was avaialble. Histologically, they all
had a varying degree of steatosis (microvesicular and macrovesicu-
lar) and inflammation, and these changes were more pronounced
in alcohol-consuming HCV patients. Frozen necropsy liver tissues
frompatients with stroke but without apparent liver pathologywere
also obtained for immunoblotting.
Gene Array Analysis of Liver Tumors. For gene profiling, the
Affymetrix mouse gene chip (GeneChip Mouse Genome 430A
2.0) was used, and analysis was performed in the Genome Core
Facility at Los Angeles Children’s Hospital. We performed
microdissection to collect hepatocytes from NS5A Tg mice fed
alcohol and wild-type (WT) mice fed alcohol for 12 months (14
months old). We prepared serial cryosections from 5 mice (3
males and 2 females) from each group, stained them with H&E,
and collected hepatocytes from non-tumor-bearing areas using
laser-capture microscopy as described previously (1–3). A min-
imum of 100200 cells were collected from each of 5 animals in
both groups, and RNA individually extracted was pooled for
each group for the analysis (1, 2, 4–6). Three different batches
of RNA from different areas were prepared and used for
microarray analysis. For gene profiling analysis, the Affymetrix
mouse gene chip (GeneChipMouse Genome 430A 2.0) was used
in the Genome Core Facility at Los Angeles Children’s Hospital.
Data analysis was performed by using Partek Pro 5.1 (Partek
Inc.). The normalization of the array data and statistical analysis
were performed as described previously (7–9).
Plasmids, Lentivirus, and Retrovirus Vectors. The NS5A expression
plasmidwas constructed by insertingHCVNS5A cDNAbehind the
CMVpromoter in pCDNA3.1 (Invitrogen). Lentivirus vectorswere
prepared by standard procedures in HEK293T cells. Three plas-
mids, packaging vector pPAX2 (Addgene), ecotropic envelope
gene expression vector pMDV (Addgene), and the cassettes of
shRNA were transfected in HEK293T cells by lipid-based trans-
fection reagent FuGene6 (Roche). The retroviral expression vec-
tors for shRNA of TLR4 and Nanog were obtained from Open
Biosystems. Retrovirus expressing TLR4 was produced in Phoenix
cells (10). After 72 hours of transfection, the virus supernatants
were harvested and mixed with polybrene (4 g/mL) and used to
infect Huh7 cells. More detailed states of the patients are depicted
in SI Methods.
Statistical Analysis. Statistical analysis of the data in Tables S1–S3
was performed by the 2 test or Student’s t test. Values of P 
0.05 were considered to be statistically significant.
SI Discussion
One potential concern about the NS5A Tg used for the present
study is that the protein may be overexpressed beyond the
physiological range in chronic HCV infection, rendering artifi-
cial effects in the model. However, our immunoblot analysis
comparing NS5A expression in livers of HCV patients and NS5A
mice reveals NS5A expression in patient samples at the level
approximating one third of the mouse Tg expression. Therefore,
the NS5A expression in our model does not appear to be too
excessive or unphysiological. In natural HCV infection, other
viral proteins are also expressed and they may have interactive
effects. Obviously, our animal model does not reproduce this
environment as it is intended to specifically test the effects of the
protein NS5A. In fact, because of this approach, we were able to
reveal the novel roles of TLR4 and Nanog in their oncogenic
potential in the context of the synergism specifically mediated by
NS5A and alcohol. The roles of JNK and IKK in liver oncogen-
esis are important questions. AP-1 is activated in both HCC and
chronic hepatitis (11). In vitro studies using liver-derived cell
lines demonstrate rapid activation of AP-1 by HBV or HCV
proteins (12). Our study also shows activation of JNK in alcohol-
fed NS5A Tg mice in concurrence with the increased risk of liver
tumors (Fig. S4). JNK-AP1 activation may induce compensatory
cell proliferation via induction of growth factors such as IL-6,
TNF-alpha, and HGF. This regenerative proliferation is consid-
ered as a predisposing condition for permanent oncogenic
mutations in initiated hepatocytes for transmission to daughter
cells (13–16). NF-kappaB activation protects the cells by induc-
tion of anti-apoptotic and anti-oxidant genes such as superoxide
dismutase (SOD). Indeed, hepatocyte IKK inhibits liver car-
cinogenesis via attenuation of oxygen radical formation, and
mice deficient in IKK are predisposed to JNK1-mediated
oxidant stress and chemically induced liver tumors (13, 15). In
our mouse model, NF-kappaB is activated by TLR4 signaling
and this activation correlates with the expression of proinflam-
matory genes such as TNF-. This pro-inflammatory response
may also augment JNK-mediated hepatocellular damage and
transformation. Our study did not address which isoform of JNK
(JNK1/2) is responsible for NS5A-TLR4 mediated liver damage
and oncogenesis, and this is an obvious question which will need
to be addressed in future studies.
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Fig. S1. Kupffer cell depletion only partially reduces LPS-induced TNF- and liver damage in NS5A Tgmice. (A) Kaplan–Meier survival curves of wild-type (WT)
andNS5ATgmice in the presence or absence of Tlr4/ after sublethal LPS challenge (25mg/kgweight, intraperitoneal injection). NS5ATgmicewere susceptible
to LPS-inducedmortality comparedwithWT or Tlr4/NS5Amice (P 0.01, log-rank test). (B) Liposome-encapusulated Clodronate efficiently eliminatedmouse
Kuppfer cells. Note Kupffer cells stained with antibodies against F4/80 were almost completely eliminated by Clodronate compared with control liposome-
injected mouse liver. (C and D) Mice were injected with liposome-encapsulated Clodronate or control liposomes, 2 days later challenged with a sublethal dose
of LPS (25 mg/kg weight, intraperitoneal injection), and observed for 72 h. Serum AST levels were determined at 24 h after LPS injection (C), and serum TNF-
levels were monitored at 1.512 h after LPS challenge (D). LPS-induced elevations of AST and TNF- were largely (7580%) prevented by Clodronate
pretreatment in WT mice. In contrast, the same treatment attenuated the same parameters only by 3539% in NS5A Tg mice. (C: *, P  0.004 compared with
NS5Agiven control liposomes, **, P 0.03 comparedwithWTgiven control liposomes;D: *, P 0.03 comparedwith NS5Agiven control liposomes, **, P 0.007
compared with WT given control liposomes).
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Fig. S2. NS5A and TLR4 induction in alcoholic HCV patients. (A) NS5A protein expression was assessed by immunoblot analysis in liver protein extracts from
stroke patients with normal livers and HCV patients without or with the history of alcoholism compared with NS5A Tg mouse livers. (B) Densitometry results of
NS5A proteins normalized by -actin are shown. HCV patients with or without alcoholism had comparably induced NS5A protein expression at the level
approximating one third of the expression observed in NS5A Tg mice. (C–F) Liver sections from healthy livers from stroke patients and hepatitis C patients with
or without alcoholism were stained for TLR4, phospho-JNK, and phospho-IB. Note colocalization signals (merged images) for TLR4 with phosphor-JNK or
phosphor-IB were increased in nonalcoholic and alcoholic HCV patients. (F) Negative control staining of liver sections from an HCV patient using isotype
nonimmune antibody.
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Fig. S3. NS5A-induced TLR4 triggers alcohol-induced submassive necrosis and enhanced oxidant damage. (A) A schematic diagramdepicting the experimental
design of 4-week intragastric ethanol feeding of different genetic mice. (B) Serum ALT of alcohol-fed NS5A transgenic mice in NS5A Tg and WT mice. Note a
more accentuated increase in serum ALT levels in NS5Amice compared withWTmice after 4 weeks of intragastric ethanol infusion. (C) Plasma endotoxin levels
in ethanol-fed NS5A Tg andWTmice compared with these mice before 4-wk intragastric infusion of ethanol. Plasma endotoxin levels were equally elevated in
ethanol-fed WT and NS5A mice. (D) Increased serum ALT levels in ethanol-fed NS5A mice were reduced in TLR4/NS5A mice fed ethanol. (E) Serum ALT of
alcohol-fed NS5A transgenic mice in the presence or absence of antibiotics or enteral LPS treatment. Antibiotics treatment kills gut bacteria, which is a source
of endotoxin. Antibiotic treatment attenuated and intragastric LPS administration augmented an increase in serum ALT levels in NS5A mice fed ethanol. (F–I)
Submassive coagulative necrosis and intense inflammation were noted in the livers from ethanol-fed NS5Amice (G) but not from ethanol-fedWTmice (F). Note
aggravated alcoholic liver pathology seen in NS5A mice was prevented in Tlr4/NS5A mice and NS5A mice given antibiotics (H and I). (J) Lipid peroxides
(4-hydroxyalkenals and malondialdehyde) of livers from wild-type and NS5A Tg mice were analyzed by a commercial assay (LPO-586; OXIS International Inc.).
Note alcohol feeding significantly increased hepatic lipid peroxide content in wild-type mice, and this increase was significantly more accentuated in NS5A Tg
mice.
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Fig. S4. Long-term alcohol feeding causes enhanced activation of TLR4 signaling in NS5A Tg mice. (A) Alcohol feeding for 12 months resulted in accentuated
TLR4 signaling, as demonstrated by enhanced interaction of TAK1with TRAF6 and increased expression of phosphor-JNK and phosphor-IB in the livers of NS5A
Tg mice compared with alcohol-fed wild-type (WT) mice or WT and NS5A Tg mice fed a control diet. (B) Accentuated TLR4 signaling in the livers of alcohol-fed
NS5ATgmicewas completelypreventedbyTLR4deficiency (Tlr4/NS5A). (C) Liver cyosections fromNS5ATgandWTmice fedalcohol for 12monthswere stained
for TLR4, TNF-, phospho-IB, and phospho-JNK. Note increased colocalization of TLR4 staining with the staining for TNF-, phospho-IB, and phospho-JNK in
alcohol-fed NS5A Tg mice compared with alcohol-fed WT mice.
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Fig. S5. Differentially regulated genes in the livers of NS5A Tg mice fed alcohol for 12 months. DNA microarray analysis was performed in the livers of NS5A
Tg mice and wild-type mice fed alcohol for 12 months as described in SI Methods. (A) This list summarizes differentially regulated genes in alcohol-fed NS5A
mouse livers for different functional groups. Of note is the 5.1-fold induction of the stem cell marker Nanog. (B) A partial list of genes up-regulated by more
than 4-fold or down-regulated by more than 2-fold in the livers of alcohol-fed NS5A Tg mice compared with alcohol-fed wild-type mice.
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Table S1. Liver histological grading of NS5A Tg mice with or without TLR deficiency after 4-week alcohol feeding
Mouse Diet
Fatty liver
(0–4)
Spotty
necrosis (0–2)
Submassive
necrosis (0–2)
Inflammation
(0–2)
WT Ethanol 2.8  0.7 0 0 0.5  0.3
NS5A Tg Ethanol 1.9  0.6 0.5  0.2 1.5  0.4† 1.4  0.6†
Tlr4 / NS5A Tg Ethanol 1.0  0.3‡ 0.1  0.2 0.1  0.1‡ 0.2  0.2‡
NS5A Tg Ethanol plus antibiotics 1.9  0.3 0.3  0.4 0.4  0.1‡ 0.3  0.4‡
NS5A Tg Ethanol plus LPS 2.2  0.5 1.8  0.5 1.6  0.2‡ 1.7  0.7‡
Fatty liver: 2, 2550% heaptocytes with fat; 3, 5075% with fat; 4, 75% with fat. Submassive necrosis/inflammation: 1, lesions encompassing less
than one third acinus; 2, lesions larger than whole acini.
†P  0.05 compared with WT.
‡P  0.05 compared with respective ethanol diet-fed NS5A Tg mice.
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Table S2. Disruption of Tlr4 prevents tumor development in NS5A Tg mice fed the alcohol diet for 12 months
Mouse Diet N Tumor, % Survival, %
Daily consumption,
mL/mouse
Serum
TNF-,
pg/mL
Body weight, g
Liver
weight, g
Ratio of liver
to bodyBegin End
WT Control 22 0 86 17.2  3.4 3  1 23.8  2.1 33.0  2.1 1.3  0.3 3.9
Tlr4/ Control 24 0 87 18.1  3.1 4  2 23.9  2.2 33.5  2.3 1.2  0.2 3.7
NS5A Tg Control 41 0 86 18.1  4.1 4  3 24.7  2.6 34.1  3.7 1.6  0.3 4.5
Tlr4/NS5A Tg Control 18 0 83 17.6  3.6 3  2 23.5  1.7 35.9  3.5 1.5  0.4 3.9
WT Ethanol 21 0 67 15.3  2.8 12  5† 25.9  2.8 31.2  2.5 1.5  0.5 5.2
Tlr4/ Ethanol 26 0 69 16.1  4.4 7  5 23.7  2.4 29.2  3.6 1.5  0.7 3.9
NS5A Tg Ethanol 42 23‡ 62 15.7  3.0 24  8§ 24.3  3.3 29.5  3.9 1.9  0.8 6.7
Tlr4/NS5A Tg Ethanol 19 0 63 16.3  4.0 9  6¶ 24.5  2.7 30.2  3.8 1.7  0.5 5.4
Thepercentageofmales and female animals in different experimental groups ranged 45–55%males and 45–53% females. The tumor incidences in the 2 sexes
in ethanol-fed TLR4 Tg mice were 13% for females and 36% for males (P  0.05, 2 test).
†P  0.05 compared with respective control diet-fed groups.
‡P  0.006 compared with all other groups.
§P  0.05 compared with ethanol-fed WT.
¶P  0.02 compared with ethanol-fed Tlr4/NS5A.
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Table S3. Sex difference of tumor development in NS5A Tg mice fed the alcohol diet for 12 months
Mouse Diet N Tumor, % Survival, % Sex, n: M/F Survived mice, n: M/F Tumor-bearing mice, n (%): M/F
WT Ethanol 21 0 68 21/20 15/13 0/0
NS5A Tg Ethanol 42 23† 62 19/23 11/15 4 (36)/2 (13)‡
†P  0.006, Student’s t test was performed to calculate statistical significance in comparison to those of WT mice.
‡P  0.736, 2 test was performed to compare incidence of tumor development in sex difference, showing no statistical sex difference.
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